Spliceosome induction is a druggable dependency of RAS-driven senescence and cancer

Journal:

Nature Communications

Published:

2026-04-15

DOI:

10.1038/s41467-026-71564-z

Affiliations:

21

Authors:

26

Go to article

Institutions	Authors	Share
Imperial College London (ICL), United Kingdom (UK)	3.916667	0.15
MRC Laboratory of Medical Sciences (LMS), United Kingdom (UK)	3.583333	0.14
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany	3.250000	0.13
University of Lisbon (ULISBOA), Portugal	2.166667	0.08
University of Tübingen (Uni Tübingen), Germany	2.000000	0.08
UCL, United Kingdom (UK)	2.000000	0.08
Gulbenkian Institute for Molecular Medicine (GIMM), Portugal	1.833333	0.07
University Hospital Tübingen (UKT), Uni Tübingen, Germany	1.250000	0.05
Wellcome Centre for Anti-Infectives Research (WCAIR), University of Dundee, United Kingdom (UK)	1.000000	0.04
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany	1.000000	0.04
Weizmann Institute of Science (WIS), Israel	1.000000	0.04
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore	1.000000	0.04
Cluster of Excellence "Image-guided and Functionally Instructed Tumor Therapies" (iFIT), Germany	0.500000	0.02
CRUK Scotland Institute, United Kingdom (UK)	0.500000	0.02
University of Glasgow, United Kingdom (UK)	0.500000	0.02
Institute of Biomedicine of Valencia (IBV), CSIC, Spain	0.250000	0.01
Centro de Investigación Príncipe Felipe (CIPF), Spain	0.250000	0.01

Interested in Oncology and Carcinogenesis?